Atorvastatin Increases the Expression of Long Non-Coding RNAs ARSR and CHROME in Hypercholesterolemic Patients: A Pilot Study
Atorvastatin is extensively used to treat hypercholesterolemia. However, the wide interindividual variability observed in response to this drug still needs further elucidation. Nowadays, the biology of long non-coding RNAs (lncRNAs) is better understood, and some of these molecules have been related...
Saved in:
Main Authors: | Isis Paez (Author), Yalena Prado (Author), Carmen G. Ubilla (Author), Tomás Zambrano (Author), Luis A. Salazar (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNA-33b is a Potential Non-Invasive Biomarker for Response to Atorvastatin Treatment in Chilean Subjects With Hypercholesterolemia: A Pilot Study
by: Carmen Gloria Ubilla, et al.
Published: (2021) -
Skeletal Muscle Type-Dependent Effect of Atorvastatin on FoxO3a and Akt in Hypercholesterolemic Rats
by: Anna Gawędzka, et al.
Published: (2023) -
Comparison of the effects of alcoholic extract of aerial parts of Anvillea garcinii and atorvastatin on the lipid profile and thyroid hormones in hypercholesterolemic rats
by: Fatemeh Rasekh, et al.
Published: (2022) -
Long non-coding RNAs (lncRNAs) in spermatogenesis and male infertility
by: Meghali Joshi, et al.
Published: (2020) -
Long non-coding RNAs: From disease code to drug role
by: Yuanyuan Chen, et al.
Published: (2021)